Tectonic Therapeutic, Inc. Common Stock TECX
Analyst Ratings
- Consensus
- Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $77.80 (+149.2% upside)
Key Stats
- Today's Range
- $28.96 – $31.97
- 50-Day Range
- $27.24 – $39.53
- 52-Week Range
- $14.38 – $39.53
- Volume
- 241K shs
- Average Volume
- 213K shs
- Market Cap
- $585.31 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.09%
- Days to Cover
- 1.00
About Tectonic Therapeutic, Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Related Stocks
Compare head-to-head: TECX vs AMGN·TECX vs MRNA·TECX vs HALO·TECX vs KRYS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.